PK/PD
Hide
Model selection and scenario comparison for dose/clearance assumptions (deterministic mock). Business and scientific purpose: de-risk progression to translational milestones with stronger efficacy, safety, and biomarker evidence. PK/PD is connected to linked entities, metrics, and workflow actions in this workspace. Use these panels to review evidence, identify risks, and decide the next best scientific action. The view uses deterministic demo data shaped to mirror realistic drug discovery operations.
| id | programId | model | cmax | clearance | fit |
|---|---|---|---|---|---|
| PKPD-001 | PRG-001 | 1-compartment | 1.4 | 6.2 | review |
| PKPD-002 | PRG-002 | 1-compartment | 1.48 | 6.32 | accepted |
| PKPD-003 | PRG-003 | 1-compartment | 1.56 | 6.44 | accepted |
| PKPD-004 | PRG-004 | 1-compartment | 1.64 | 6.56 | accepted |
| PKPD-005 | PRG-005 | 1-compartment | 1.72 | 6.68 | review |
| PKPD-006 | PRG-006 | 1-compartment | 1.8 | 6.8 | accepted |
| PKPD-007 | PRG-007 | 1-compartment | 1.88 | 6.92 | accepted |
| PKPD-008 | PRG-008 | 1-compartment | 1.96 | 7.04 | accepted |
| PKPD-009 | PRG-009 | 1-compartment | 2.04 | 7.16 | review |
| PKPD-010 | PRG-010 | 1-compartment | 2.12 | 7.28 | accepted |
| PKPD-011 | PRG-011 | 1-compartment | 2.2 | 7.4 | accepted |
| PKPD-012 | PRG-012 | 1-compartment | 2.28 | 7.52 | accepted |
| PKPD-013 | PRG-013 | 1-compartment | 2.36 | 7.64 | review |
| PKPD-014 | PRG-014 | 1-compartment | 2.44 | 7.76 | accepted |
| PKPD-015 | PRG-015 | 1-compartment | 2.52 | 7.88 | accepted |
| PKPD-016 | PRG-016 | 1-compartment | 2.6 | 8 | accepted |
| PKPD-017 | PRG-017 | 1-compartment | 2.68 | 8.12 | review |
| PKPD-018 | PRG-018 | 1-compartment | 2.76 | 8.24 | accepted |
| PKPD-019 | PRG-019 | 1-compartment | 2.84 | 8.36 | accepted |
| PKPD-020 | PRG-020 | 1-compartment | 2.92 | 8.48 | accepted |